| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OncoSil Medical Limited (AU: OSL)
OSL Technical Analysis
1
| As on 14th Jan 2025 OSL STOCK Price closed @ 0.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OSLSTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.00 | 1 Day | N/A | N/A |
| Low | 0.00 | 1 Week | 0.00 | 0.00 |
| Close | 0.00 | 1 Month | 0.00 | 0.00 |
| Volume | 1151191 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.00 | 52 Week Low 0.00 | ||||
AU Australia Most Active Stocks
| SGR | 0.14 | 16.67% |
| WML | 0.00 | % |
| TMG | 0.05 | 0.00% |
| ROG | 0.01 | 0.00% |
| VEN | 0.01 | % |
| PLS | 2.20 | 0.00% |
| RDN | 0.01 | 0.00% |
| SYA | 0.02 | 0.00% |
| HWK | 0.09 | % |
| MGR | 1.86 | 1.64% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| OSL Daily Charts |
OSL Intraday Charts |
Whats New @ Bazaartrend |
OSL Free Analysis |
|
|
OSL Important Levels Intraday
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
OSL Forecast January 2025
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
OSL Weekly Forecast
| 4th UP Forecast | 0.00 |
| 3rd UP Forecast | 0.00 |
| 2nd UP Forecast | 0.00 |
| 1st UP Forecast | 0.00 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | 0.00 |
OSL Forecast2025
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
OncoSil Medical Limited ( AU Australia Symbol : OSL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OSL Business Profile
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and bile duct cancer in Australia. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia. Address: 15 Blue Street, North Sydney, NSW, Australia, 2060
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service